Amneal Pharmaceuticals, Inc. (AMRX)
17.78
-0.13
(-0.73%)
USD |
NASDAQ |
Aug 24, 16:00
17.77
-0.01
(-0.06%)
After-Hours: 20:00
Amneal Pharmaceuticals Shareholders Equity (Quarterly) : 33.02M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.02M |
| March 31, 2026 | -45.41M |
| December 31, 2025 | -70.79M |
| September 30, 2025 | -109.46M |
| June 30, 2025 | -112.12M |
| March 31, 2025 | -131.67M |
| December 31, 2024 | -109.27M |
| September 30, 2024 | -93.43M |
| June 30, 2024 | -57.46M |
| March 31, 2024 | -63.72M |
| December 31, 2023 | 19.78M |
| September 30, 2023 | 330.86M |
| June 30, 2023 | 318.17M |
| March 31, 2023 | 294.41M |
| December 31, 2022 | 298.42M |
| September 30, 2022 | 297.47M |
| June 30, 2022 | 280.33M |
| March 31, 2022 | 391.12M |
| December 31, 2021 | 360.34M |
| September 30, 2021 | 350.51M |
| June 30, 2021 | 346.11M |
| March 31, 2021 | 323.02M |
| December 31, 2020 | 303.27M |
| September 30, 2020 | 301.04M |
| June 30, 2020 | 306.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 318.38M |
| December 31, 2019 | 232.01M |
| September 30, 2019 | 218.00M |
| June 30, 2019 | 459.66M |
| March 31, 2019 | 472.20M |
| December 31, 2018 | 504.75M |
| September 30, 2018 | 501.10M |
| June 30, 2018 | 494.50M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -385.74M |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | 540.88M |
| December 31, 2016 | 623.97M |
| September 30, 2016 | 903.86M |
| June 30, 2016 | 1.073B |
| March 31, 2016 | 1.069B |
| December 31, 2015 | 1.062B |
| September 30, 2015 | 1.029B |
| June 30, 2015 | 987.68M |
| March 31, 2015 | 894.33M |
| December 31, 2014 | 887.88M |
| September 30, 2014 | 888.50M |
| June 30, 2014 | 868.74M |
| March 31, 2014 | 825.18M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Liquidia Corp. | 195.11M |
| Eli Lilly & Co. | 33.88B |
| Indivior Pharmaceuticals, Inc. | -208.00M |
| Viatris, Inc. | 14.26B |
| Pfizer Inc. | 85.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.776B |
| Total Liabilities (Quarterly) | 3.659B |
| Debt to Equity Ratio | 84.54 |
| Current Ratio | 2.204 |
| Net Debt Paydown Yield | -0.77% |